ArticleAnalytica chimica acta2025
MALDI matrix sublimation versus spray coating in the FluoMALDI imaging pipeline.
Article in Analytica chimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- MALDI Mass Spectrometry Imaging in Alzheimer's Disease Lipidomics: Matrix Selection, Spatial Lipid Pathology and Emerging Analytical Strategies.International journal of molecular sciences · 2026Review
- Dry Deposition Strategies for MALDI-MS Imaging: Principles, Advances and Emerging Applications.Analytical science advances · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThis study advances the FluoMALDI pipeline for tissue autofluorescence applications by integrating slide-scanning fluorescence microscopy (SSFM) with matrix-assisted laser desorption/ionization (MALDI) imaging to target autofluorescent tissue structures.
resultsMouse brain, liver, and kidney tissues were used to systematically compare the two matrix deposition methods of sublimation and spray coating in the FluoMALDI pipeline. Half of each tissue section was left uncoated as control by covering it during matrix application. Six MALDI matrices including 9-aminoacridine, norharmane, α-cyano-4-hydroxycinnamic acid, 2,5-dihydroxyacetophenone, 2,5-dihydroxybenzoic acid, or sinapinic acid were applied in equal amounts. Autofluorescence enhancements were evaluated using three fluorescence channels in the green, red, and far-red range of the spectrum, revealing matrix- and tissue-dependent fluorescence enhancement profiles. Norharmane matrix resulted in the most consistent tissue autofluorescence enhancements across deposition methods, with the highest enhancements in the green channel when applied by spray coating, and in the red and far-red channels when applied by sublimation coating. Matrix crystal size did not significantly impact the observed fluorescence enhancement effects for all six tested matrices. The two ionization modes of MALDI-1 and MALDI-2 imaging were also compared on brain, liver, and kidney tissue sections to assess lipid detection efficiency and spatial distribution in the FluoMALDI imaging pipeline. While the spatial distributions of phosphatidylethanolamine (PE) and phosphatidylcholine (PC) species were consistent across MALDI ionization modes and matrix deposition methods, lipid detection efficiency varied depending on the matrix type, matrix crystal size, tissue type, and MALDI ionization mode. Sublimation, which produced fine crystals without solvents, generally resulted in higher phospholipid detection efficiency than spray coating for lipids including PE(36:2) and PC(36:2) in both MALDI-1 and MALDI-2 imaging. SIGNIFICANCE: These findings highlight that the matrix choice and matrix deposition method applied significantly affect tissue autofluorescence enhancement, spatial resolution, and lipid detection efficiency in MALDI-1 and MALDI-2 imaging modes, offering valuable insights for selecting optimal matrix deposition for FluoMALDI imaging based on a given study's research goals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.